L302-0075 Screening compound: 1-acetyl-N-[(2H-1,3-benzodioxol-5-yl)methyl]-3,3-dimethyl-2,3-dihydro-1H-indole-5-sulfonamide

L302-0075 Screening compound: 1-acetyl-N-[(2H-1,3-benzodioxol-5-yl)methyl]-3,3-dimethyl-2,3-dihydro-1H-indole-5-sulfonamide
L302-0075 Screening compound: 1-acetyl-N-[(2H-1,3-benzodioxol-5-yl)methyl]-3,3-dimethyl-2,3-dihydro-1H-indole-5-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L302-0075
1-acetyl-N-[(2H-1,3-benzodioxol-5-yl)methyl]-3,3-dimethyl-2,3-dihydro-1H-indole-5-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L302-0075

Molecular Formula

C20H22N2O5S (C20 H22 N2 O5 S)

Compound Name

1-acetyl-N-[(2H-1,3-benzodioxol-5-yl)methyl]-3,3-dimethyl-2,3-dihydro-1H-indole-5-sulfonamide

IUPAC name

1-acetyl-N-[(2H-13-benzodioxol-5-yl)methyl]-33-dimethyl-23-dihydro-1H-indole-5-sulfonamide

SMILES

CC(C)(C1)c(cc(cc2)S(NCc(cc3)cc4c3OCO4)(=O)=O)c2N1C(C)=O

InChI

InChI=1S/C20H22N2O5S/c1-13(23)22-11-20(2,3)16-9-15(5-6-17(16)22)28(24,25)21-10-14-4-7-18-19(8-14)27-12-26-18/h4-9,21H,10-12H2,1-3H3

InChI Key

VRABBVUKIXHDGF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27242688

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

402.47

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.149

Distribution Coefficient, logD

3.149

Water Solubility, LogSw

-3.62

Polar Surface Area

75.464

Acid Dissociation Constant (pKa)

10.94

Base Dissociation Constant (pKb)

-1.99

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.00

L302-0075 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L302-0075 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L302-0075?
Check Price and Availability of L302-0075, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L302-0075 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L302-0075
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L302-0075
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L302-0075 available by request